AJNA BioSciences is a botanical drug development company focused on psilocybin and other naturally derived psychedelics to target innovative new therapies for depression, addiction, PTSD, Alzheimer’s and Parkinson’s diseases.

WE ARE

AJNA Biosciences is pioneering naturally-engineered psychedelic treatments for mental health and neurological disorders, innovating market-driven options by accelerating accessible pathways to consumers.

“Simply by empowering consumers with a choice that otherwise doesn't exist we're going to disrupt the entire healthcare paradigm with new options, healthier options, safer options.”

Joel Stanley
AJNA Co-Founder and CEO
Former CEO and Chairman of the Board, Charlotte's Web

A MULTI-COMPOUND APPROACH,
A MULTITUDE OF TREATMENTS.

From the founders of Charlotte's Web, that brought full-spectrum CBD to millions of health seekers, comes a new venture into the world of botanical drug development, leading with earth-derived psychedelics.

Harmonizing mental and physical health relies on integrating naturally-engineered options with phyto- and myco-based therapies. By engineering natural medicine through multi-compound solutions, Ajna Biosciences reimagines consumer wellness with a new FDA approved class of botanically-derived drugs.

Quite frankly, clinical patients need more options. Conventional medications simply don’t work for everyone. And, who better to lead the charge than the Stanley Brothers who did it before with cannabinoid based products.

Dr. Staci Gruber
Director, MIND Clinic, Maclean Hospital
Associate Professor of Psychiatry and Behavioral Sciences, Harvard Medical School.
AJNA Scientific Board Member

''

AN UNTAPPED MARKET,
A UNIVERSAL NEED

AJNA endeavors to shift consumers from the constricted status quo of traditional pharmaceuticals to an entirely new class of standardized and efficacious botanical drugs via FDA approval.

With a global pharmaceutical market at nearly $1.3 Trillion USD, people are seeking botanical options at an exponential rate, yet often lacking in botanical choices. 

ARCHITECTING NATURE
INTO NURTURE

Made by earth.
Engineered by science.
Created for humans.

Leveraging advanced research and cultivation, AJNA imagines botanical medicine as a complete ecosystem, designing solutions for mind to body health.

INVESTING IN
THE FUTURE

The cost of treating mental health and the opportunity for groundbreaking solutions.

$42B

Addiction

Global Annual 2027 Forecast

$24.9B

ADHD

Global Annual 2025 Forecast

$19B

Depression & Anxiety

Global Annual 2027 Forecast

Medication research for psychiatric disorders has been stagnant. Psychedelics represent a novel mechanism of action for psychiatric drug development. Having a new class of drugs is going to be an exciting new avenue for research and could be a very important alternative to existing treatments. What’s needed is companies like AJNA to bring a pharmaceutical approach to developing these medications and doing the proper research to bring them to market.

Dr. Ryan Vandrey, Johns Hopkins University
Professor of Psychiatry and Behavioral Sciences
Director, Cannabinoid Research Unit
AJNA Scientific Board Member

''

UNEARTHING A WORLD OF POTENTIAL

Four Pathways. Hundreds of Molecules.
Millions of Lives.

For the treatment of:
Depression, Anxiety, PTSD & Addiction

Psilocybin

LSA

MAOI

MDMA

THE AJNA DIFFERENCE

A legacy of disrupting markets. A focus on standardization and efficacy. A vision of earth meeting lab through regenerative farming practices. A new future of medicine, brought to you by AJNA.

ENGINEERING LAB

R&D + BDS formulation & manufacturing

State of the art cultivation site

Diverse and untapped compounds through expansive culture library

CULTIVATION

Innovative legacy cultivation practices

Regenerative agriculture partnerships

A global imprint of versatile facilties

STANLEY BROTHERS

Global market disruptors in multi-compound wellness

Market leadership through innovation and community care

Leading manufacturing, research, and distribution

We don't come from a lab. Every cell in our being comes from the food we eat, comes from these plants, from these fungi, from the air we breathe. We ARE nature. We come from the earth, we're a part of the earth. And it stands to reason that in many cases, our best medicines are also going to come from the earth - from the botanicals, from the fungi around us.

Joel Stanley
AJNA Founder
Former CEO and Chairman of the Board, Charlotte's Web

''

HUMAN + EARTH IN PARTNERSHIP

As a public benefit corporation, we are committed to ESG principles, embracing a new way of doing good.

Environmental

Preserving natural resources, and upholding the highest quality standards to promote a sustainable future.

Social

Supporting local communities and indigenous cultures where we operate.

Governance

Supporting diversity within our team, strategic partners, investors , and the AJNA ecosystem.

THE EARTH IS RICH IN SOLUTIONS,
AJNA IS DEEP IN EXPERIENCE

A team that brings science, technology, innovation, and ethics together to create a new vision for the future.

BOARD OF DIRECTORS

TEAM MEMBERS

SCIENTIFIC ADVISORY BOARD

Contact Form

Full name
Phone
Email
Comments
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.